News
AbbVie has struck an immuno-oncology licensing agreement with IGI Therapeutics that is potentially worth more than $1.9 billion to the clinical-stage biotechnology company.
26m
Investor's Business Daily on MSNDow Jones Futures: Nvidia Chipmaker Rises, Delta Flies; AI Plays Rubrik, Astera Labs Flash Buy SignalsNvidia chipmaker Taiwan Semi reported strong sales while Delta stock flew on Q2 results. On Wednesday, Nvidia stock briefly ...
US Stock futures slipped early Thursday after the S&P 500 recouped some of its losses from this week's tariff-fueled slide. S ...
Dow Futures dip as Trump’s tariff threats stir tension; tech rally, Fed debate, and bond demand shape Wall Street outlook.
Malaysia's central bank has finally joined its rate-cutting peers, lowering its benchmark interest rate for the first time in five years to support the economy. The Italian lender now owns around 20% ...
Oil prices were swinging between gains and losses but remained modestly higher for the week, supported by a weaker dollar as Trump's new tariff rates weighed on sentiment. The Organization of the ...
Trump slapped a 50% tariff on Brazil, and Brazilian President Luiz Inacio Lula da Silva said his country would respond.
Dow, S&P 500, and Nasdaq futures are falling in premarket trading. An Nvidia-led rally fades as the stock market react to President Donald Trump threating a 50% tariff on goods from Brazil.
U.S. stocks settled higher on Wednesday, with the Dow Jones index gaining more than 200 points during the session as ...
In this article, we focused on the 10 best-performing mid-cap companies on the stock market, which were noticeably dominated ...
The Nasdaq hit a record high as Nvidia briefly reached $4T in value and major tech stocks rallied on renewed enthusiasm for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results